Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Barium sulfate is an inorganic compound used as a radiographic contrast agent to enhance the visibility of the gastrointestinal (GI) tract in diagnostic imaging procedures such as X-rays and computed tomography (CT) scans. It works by coating the lining of the esophagus, stomach, or intestines with a radiopaque material that is not absorbed into the body. This allows for clear visualization of diseased or damaged areas during imaging. Barium sulfate is administered orally or rectally and is primarily indicated for use in adults and pediatric patients undergoing GI tract examinations[1][2][3][5]. The compound occurs naturally as barite and has very low water solubility and high clearance from the body[3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on barium sulfate.